The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells
Open Access
- 15 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 25 (3) , 281-288
Abstract
The aim of the present investigation is to determine whether the quercetin in combination with cisplatin can ameliorate cisplatin-induced clastogenesis and apoptosis in the bone marrow cells of mice. The scoring of chromosomal aberrations, micronuclei and mitotic activity were undertaken in the current study as markers of clastogenicity. Apoptosis was analysed by the Annexin V–propidium iodide assay and the occurrence of a hypodiploid DNA peak. Oxidative stress markers such as bone marrow lipid peroxidation and reduced glutathione were assessed as a possible mechanism underlying this amelioration. Quercetin was neither clastogenic nor apoptogenic in mice at doses equivalent to 50 or 100 mg/kg for 2 days. Pre-treatment of mice with quercetin significantly reduced cisplatin-induced clastogenesis and apoptosis in the bone marrow cells and these effects were dose and time dependent. Prior administration of quercetin ahead of cisplatin challenge ameliorated oxidative stress markers. Overall, this study provides for the first time that quercetin has a protective role in the abatement of cisplatin-induced clastogenesis and apoptosis in the bone marrow cells of mice that resides, at least in part, in its antioxidant effects. Therefore, quercetin can be a good candidate to decrease the deleterious effects of cisplatin in the bone marrow cells of cancer patients treated with this drug.Keywords
This publication has 46 references indexed in Scilit:
- Fifty years of cytogenetics: A parallel view of the evolution of cytogenetics and genotoxicologyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008
- Heme Oxygenase-1 in Tumors: Is It a False Friend?Antioxidants & Redox Signaling, 2007
- Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled studyEuropean Journal of Cancer, 2004
- Assessment of the adaptive response induced by quercetin using the MNCB peripheral blood human lymphocytes assayMutagenesis, 2000
- Effect of preinductin of metallothionein synthesis on clastogenicity of anticancer drugs in miceMutation Research Letters, 1995
- Cisplatin Generates Superoxide Anion by Interaction with DNA in a Cell-Free SystemBiochemical and Biophysical Research Communications, 1994
- Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinomaEnvironmental and Molecular Mutagenesis, 1991
- Clastogenic effects of cis-diamminedichloroplatinumMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
- Micronucleus test in bone marrow of mice treated with 1-nitropropane, 2-nitropropane and cisplatinMutation Research Letters, 1987
- Kinetics of micronucleus formation in relation to chromosomal aberrations in mouse bone marrowMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1984